Premium
Phosphorylation of epidermal growth factor receptor and chromosome 7 polysomy in gastric adenocarcinoma
Author(s) -
ZHANG Fan,
TANG Jian Min,
WANG Li,
SHEN Jing Ying,
ZHENG Lin,
WU Ping Ping,
ZHANG Mei,
YAN Zhao Wen
Publication year - 2012
Publication title -
journal of digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.684
H-Index - 51
eISSN - 1751-2980
pISSN - 1751-2972
DOI - 10.1111/j.1751-2980.2012.00597.x
Subject(s) - polysomy , medicine , adenocarcinoma , dysplasia , cancer , epidermal growth factor receptor , cancer research , immunohistochemistry , fluorescence in situ hybridization , pathology , chromosome , gene , biology , biochemistry
OBJECTIVE: To investigate the phosphorylation of epidermal growth factor receptor (EGFR) and its potentially associated chromosomal aberrations in gastric adenocarcinoma. METHODS: Phosphorylated EGFR (pEGFR) was detected by immunohistochemistry on 145 specimens including 60 tumoral, 60 non‐tumoral, 12 tumor‐adjacent intramucosal dysplasia from patients with gastric adenocarcinoma and 13 mucosae from cancer‐free patients. EGFR gene amplification and chromosome 7 (Chr‐7) polysomy were detected by fluorescence in situ hybridization. RESULTS: Positivity of pEGFR was found in 50 tumoral (83.3%) and 42 non‐tumoral specimens (70.0%). There was an association between tumoral and non‐tumoral zones on immunostains of pEGFR ( r = 0.353, P = 0.006). Nuclear pEGFR usually presented in mucosae with Helicobacter pylori infection, stromal reaction or vascular invasion. Cytoplasmic pEGFR was correlated with local cancer extension ( r = 0.337, P = 0.014) and inversely related with gastrokine 2, which had been previously detected in the same specimens. Eleven intramucosal dysplastic specimens were also positive for pEGFR while 13 mucosae from cancer‐free patients were all negative. No EGFR gene amplification was observed. However, seven tumor specimens showed Chr‐7 polysomy (11.7%) in which 5 were strongly positive for pEGFR. CONCLUSIONS: EGFR phosphorylation may be one of the mechanisms that promote tumor initiation and expansion in gastric adenocarcinoma. Detection of pEGFR with analysis of its nuclear or cytoplasmic patterns could be clinicopathologically valuable. Chr‐7 polysomy may partially contribute to EGFR activation in gastric adenocarcinoma, although its role does not predominate.